Mirabaud & Cie
LLY icon

Mirabaud & Cie’s Eli Lilly LLY Stock Holding History

Mirabaud & Cie’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.34M Sell
2,886
-65
-2% -$76.7K 1.29% 17
2026
Q2 		$3.54M Sell
2,951
-4,513
-60% -$4.61M 1.42% 15
2026
Q1 		$6.87M Sell
7,464
-5,039
-40% -$5.11M 2.79% 9
2025
Q4 		$13.4M Sell
12,503
-192
-2% -$184K 4.33% 8
2025
Q3 		$9.7M Buy
12,695
+350
+3% +$260K 3.08% 10
2025
Q2 		$9.6M Buy
12,345
+6,658
+117% +$5.17M 3.06% 10
2025
Q1 		$4.7M Buy
+5,687
New +$4.73M 1.6% 17

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.2B AUM 25.19% 1-Year Est. Return
Sapient Capital
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $92B AUM 22.91% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Mirabaud & Cie's LLY Position: Q3 2026 in Review

Mirabaud & Cie reduced its Eli Lilly (LLY) stake by 2.2% in Q3 2026, selling an estimated $76.7K and leaving 2,886 shares worth $3.34M. The position accounts for 1.29% of the portfolio, ranked #17.

Mirabaud & Cie first reported a position in LLY in Q1 2025 and has held it in 7 quarters since. The position peaked at $13.4M in Q4 2025. 2,688 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Mirabaud & Cie held 2,886 shares of Eli Lilly worth $3.34M as of Q3 2026.
  • Mirabaud & Cie sold 65 Eli Lilly shares in Q3 2026, an estimated $76.7K.
  • Eli Lilly made up 1.29% of Mirabaud & Cie's portfolio in Q3 2026, its #17 holding.
  • Mirabaud & Cie first reported a position in Eli Lilly in Q1 2025 and has held it in 7 quarters since.
  • Mirabaud & Cie's Eli Lilly position peaked at $13.4M in Q4 2025.
  • 2,688 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Mirabaud & Cie's 13F filing for Q3 2026, filed 27 Oct 2026.